Catalyst Wire Dossier Catalyst Wire Dossier

Levetiracetam in Sodium Chloride (IV formulation)

levetiracetam · Eugia US LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Levetiracetam in Sodium Chloride (IV formulation), covering 2023-05-23 to 2023-05-23. Get the full timeline:

Most recent: FDA Approved: LEVETIRACETAM — Supplemental Application (Eugia US LLC)

See pricing